152 related articles for article (PubMed ID: 34793841)
21. The susceptibility of circulating human influenza viruses to tizoxanide, the active metabolite of nitazoxanide.
Tilmanis D; van Baalen C; Oh DY; Rossignol JF; Hurt AC
Antiviral Res; 2017 Nov; 147():142-148. PubMed ID: 28986103
[TBL] [Abstract][Full Text] [Related]
22. [Sensitivity of various influenza virus strains to arbidol. Influence of arbidol combination with different antiviral drugs on reproduction of influenza virus A].
Leneva IA; Fediakina IT; Gus'kova TA; Glushkov RG
Ter Arkh; 2005; 77(8):84-8. PubMed ID: 16206613
[TBL] [Abstract][Full Text] [Related]
23. Intracytoplasmic trapping of influenza virus by a lipophilic derivative of aglycoristocetin.
Vanderlinden E; Vanstreels E; Boons E; ter Veer W; Huckriede A; Daelemans D; Van Lommel A; Rőth E; Sztaricskai F; Herczegh P; Naesens L
J Virol; 2012 Sep; 86(17):9416-31. PubMed ID: 22740402
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo influenza virus-inhibitory effects of viramidine.
Sidwell RW; Bailey KW; Wong MH; Barnard DL; Smee DF
Antiviral Res; 2005 Oct; 68(1):10-7. PubMed ID: 16087250
[TBL] [Abstract][Full Text] [Related]
25. Identification of dihydroorotate dehydrogenase inhibitor, vidofludimus, as a potent and novel inhibitor for influenza virus.
Li J; Takeda M; Imahatakenaka M; Ikeda M
J Med Virol; 2024 Jan; 96(1):e29372. PubMed ID: 38235544
[TBL] [Abstract][Full Text] [Related]
26. Influenza virus resistance to antiviral agents: a plea for rational use.
Poland GA; Jacobson RM; Ovsyannikova IG
Clin Infect Dis; 2009 May; 48(9):1254-6. PubMed ID: 19323631
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and in vitro biological evaluation of novel 6-methyl-7-substituted-7-deaza purine nucleoside analogs as anti-influenza A agents.
Lin C; Sun C; Liu X; Zhou Y; Hussain M; Wan J; Li M; Li X; Jin R; Tu Z; Zhang J
Antiviral Res; 2016 May; 129():13-20. PubMed ID: 26802557
[TBL] [Abstract][Full Text] [Related]
28. Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro.
Nguyen JT; Hoopes JD; Smee DF; Prichard MN; Driebe EM; Engelthaler DM; Le MH; Keim PS; Spence RP; Went GT
Antimicrob Agents Chemother; 2009 Oct; 53(10):4115-26. PubMed ID: 19620324
[TBL] [Abstract][Full Text] [Related]
29. In vitro evaluation of synergistic inhibitory effects of neuraminidase inhibitors and methylglyoxal against influenza virus infection.
Charyasriwong S; Watanabe K; Rahmasari R; Matsunaga A; Haruyama T; Kobayashi N
Arch Med Res; 2015 Jan; 46(1):8-16. PubMed ID: 25523147
[TBL] [Abstract][Full Text] [Related]
30. The importance of IMP dehydrogenase inhibition in the broad spectrum antiviral activity of ribavirin and selenazofurin.
Robins RK; Revankar GR; McKernan PA; Murray BK; Kirsi JJ; North JA
Adv Enzyme Regul; 1985; 24():29-43. PubMed ID: 2872781
[TBL] [Abstract][Full Text] [Related]
31. Punicalagin is a neuraminidase inhibitor of influenza viruses.
Li P; Du R; Chen Z; Wang Y; Zhan P; Liu X; Kang D; Chen Z; Zhao X; Wang L; Rong L; Cui Q
J Med Virol; 2021 Jun; 93(6):3465-3472. PubMed ID: 32827314
[TBL] [Abstract][Full Text] [Related]
32. D282, a non-nucleoside inhibitor of influenza virus infection that interferes with de novo pyrimidine biosynthesis.
Smee DF; Hurst BL; Day CW
Antivir Chem Chemother; 2012 Aug; 22(6):263-72. PubMed ID: 22516927
[TBL] [Abstract][Full Text] [Related]
33. Synergistic effect of nitazoxanide with neuraminidase inhibitors against influenza A viruses in vitro.
Belardo G; Cenciarelli O; La Frazia S; Rossignol JF; Santoro MG
Antimicrob Agents Chemother; 2015 Feb; 59(2):1061-9. PubMed ID: 25451059
[TBL] [Abstract][Full Text] [Related]
34. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents.
Franchetti P; Grifantini M
Curr Med Chem; 1999 Jul; 6(7):599-614. PubMed ID: 10390603
[TBL] [Abstract][Full Text] [Related]
35. Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza.
Huang CT; Hung CY; Hseih YC; Chang CS; Velu AB; He YC; Huang YL; Chen TA; Chen TC; Lin CY; Lin YC; Shih SR; Dutta A
Phytomedicine; 2019 Nov; 64():152904. PubMed ID: 31454654
[TBL] [Abstract][Full Text] [Related]
36. Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.
Stephenson I; Democratis J; Lackenby A; McNally T; Smith J; Pareek M; Ellis J; Bermingham A; Nicholson K; Zambon M
Clin Infect Dis; 2009 Feb; 48(4):389-96. PubMed ID: 19133796
[TBL] [Abstract][Full Text] [Related]
37. In Vitro Combinations of Baloxavir Acid and Other Inhibitors against Seasonal Influenza A Viruses.
Checkmahomed L; Padey B; Pizzorno A; Terrier O; Rosa-Calatrava M; Abed Y; Baz M; Boivin G
Viruses; 2020 Oct; 12(10):. PubMed ID: 33049959
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of Calcineurin or IMP Dehydrogenase Exerts Moderate to Potent Antiviral Activity against Norovirus Replication.
Dang W; Yin Y; Wang Y; Wang W; Su J; Sprengers D; van der Laan LJW; Felczak K; Pankiewicz KW; Chang KO; Koopmans MPG; Metselaar HJ; Peppelenbosch MP; Pan Q
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807916
[TBL] [Abstract][Full Text] [Related]
39. A Small-Molecule Compound Has Anti-influenza A Virus Activity by Acting as a ''PB2 Inhibitor".
Liu T; Liu M; Chen F; Chen F; Tian Y; Huang Q; Liu S; Yang J
Mol Pharm; 2018 Sep; 15(9):4110-4120. PubMed ID: 30102858
[TBL] [Abstract][Full Text] [Related]
40. The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA.
Zhou S; Liu R; Baroudy BM; Malcolm BA; Reyes GR
Virology; 2003 Jun; 310(2):333-42. PubMed ID: 12781720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
